Efficacy and Safety Evaluation of Changes in Lower Extremity Edema of Radiofrequency

January 6, 2022 updated by: Yong-il Shin, Pusan National University Yangsan Hospital

Efficacy and Safety Evaluation of Changes in Lower Extremity Edema of Radiofrequency in Adult Women With Idiopathic Edema: Blinded, Cross-over, Pilot Study

The purpose of this study is to verify the efficacy and safety of the radiofrequency stimulation compared to the sham stimulation in reducing lower extremity edema in adult women with idiopathic edema.

Study Overview

Status

Completed

Conditions

Detailed Description

In this study, based on the characteristics of radiofrequency, it was hypothesized that radiofrequency could have an effect on the reduction of lower extremity edema and prevention of fatigue. The occurrence of edema is interpreted as a problem that blood circulation is not smooth due to increased inflow of body fluid, and therefore the degree of edema is also used as an indicator of blood circulation.

Therefore, in this study, based on the principle that radiofrequency promotes phosphorylation and blood circulation, the purpose of this study is to investigate whether radiofrequency treatment is effective in reducing edema of the lower extremities and changing body heat in the lower extremities compared to the gastric stimulation device through exploratory research.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yangsan
      • Gyeongsang, Yangsan, Korea, Republic of, 50610
        • Pusan National University Yangsan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 72 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Women between the ages of 19 and 72
  2. Those who are not likely to menstruate during the trial treatment period (3 days) (females within 8 to 18 days after the onset of menstruation)
  3. Those who meet the diagnostic criteria for idiopathic edema (McKendry criteria score of 15 or higher)
  4. Those who show a weight change of 1.4 kg or more between morning and night measurements
  5. Those who have a difference of 1cm or more from the ankle or 2cm or more from the calf when measuring the circumference in the morning and evening
  6. Those who voluntarily agree to participate in this clinical trial and sign the consent form

Exclusion Criteria:

  1. In the case of using a heart rate control device such as a metallic substance in the human body
  2. During menstruation or if there is a possibility of pregnancy
  3. If you have heart disease
  4. If you have liver or kidney disease
  5. If there is bleeding or internal bleeding from wounds or surgery
  6. For hypertensive patients
  7. For epilepsy patients
  8. If you are taking weight loss or health-related drugs/health functional foods
  9. In the case where it is judged by the principal investigator that participation in this study is not appropriate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: radiofrequency stimulation
Participants received radiofrequency stimulation three times a day for 30 minutes once a day. After the end of the first session intervention, there was a washout period and the next intervention was started at a time point when the next menstruation was not likely (8-18 days after the onset of menstruation).
Radiofrequency of 9.50v, 218.5mA and 2.076W is applied once a day for 30 minutes, a total of 3 times
Other Names:
  • high frequency
Sham Comparator: sham stimulation
Participants received a sham stimulation similar to a radiofrequency stimulation three times a day for 30 minutes once a day. After the end of the first session intervention, there was a washout period and the next intervention was started at a time point when the next menstruation was not likely (8-18 days after the onset of menstruation).
The appearance is the same as the medical device for clinical trials, and when applied, the sound and the amount of light visible from the outside are designed to be the same as the medical device for clinical trials. The external light was the same, and only the high frequency that stimulates the dermis was blocked. The sham device was applied once a day for 30 minutes, a total of 3 times.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Circumference(the lower calf at 7 cm proximal to the midpoint of the medial malleolus, behind the medial malleolus, and the dorsum of the foot)
Time Frame: Changes of circumference before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
Circumference was measured using a tape measure at three anatomical locations.
Changes of circumference before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Volume
Time Frame: Changes of volume before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

The leg volume test is measured using Volumeters (Deluxe Foot) of Jeongdo BNP Co., Ltd. in Korea.

Measure using the principle of overflowing, fill a cylinder with a diameter of 30cm and a height of 30cm with water, put one leg in the cylinder with the ankle bent at 90 degrees, and take the overflowing water and measure the amount in ml.

Changes of volume before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
digital infrared thermal imaging(DITI)
Time Frame: Changes of body heat before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
Measure the subject's leg body heat using DITI.
Changes of body heat before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
Visual analog scale(VAS)
Time Frame: Changes of VAS score before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
Discomfort VAS is used to measure the degree of discomfort for lower extremity edema after application of the device. And 0 indicates no discomfort at all, and 10 indicates the most severe discomfort imaginable.
Changes of VAS score before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
weight
Time Frame: Changes of weight before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group
Measure the participant's weight (kg) using a scale.
Changes of weight before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Young-Il Shin, Pusan National University Yangsan Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2020

Primary Completion (Actual)

April 21, 2021

Study Completion (Actual)

May 21, 2021

Study Registration Dates

First Submitted

June 9, 2021

First Submitted That Met QC Criteria

January 6, 2022

First Posted (Actual)

January 11, 2022

Study Record Updates

Last Update Posted (Actual)

January 11, 2022

Last Update Submitted That Met QC Criteria

January 6, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 03-2020-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Edema

Clinical Trials on radiofrequency

Subscribe